Product category:
General lab equipment
News Release from: Syrris | Subject: Lara CLR, Coflux
Edited by the Laboratorytalk Editorial
Team on 30 September 2005
Now North American distributor of Lara
and Coflux
Syrris has been appointed distributor of the Lara controlled lab reactor (CLR) and the Coflux reaction monitoring and calorimetry system in North America
The Lara CLR is a flexible and modular chemical reactor that is both affordable and highly automated It can accommodate variable vessel size, ranging from 100ml to five litres, and it incorporates easy-to-use software which allows extensive reaction design and full data logging
This article was originally published on Laboratorytalk on 16 Jun 2004 at 8.00am (UK)
Related stories
Go with the flow for faster optimisation
Microreactor to accelerate compound discovery and process development combines both reaction optimisation and synthesis using micro-scale flow technology
Flow chemistry goes mainstream
Syrris has signed an agreement and supplied one of its new Africa microreactor systems to Professor Steven Ley at the department of chemistry at the University of Cambridge
The Coflux (constant flux) system uses the Lara CLR software to gather real-time reaction data such as power and enthalpy change.
With minimal calibration, accurate temperature measurements are afforded through a uniquely designed thermal jacket comprising of numerous coolant tubes surrounding the reaction vessel.
Making the announcement, Richard Gray, commercial director, said "We have experienced great success with the Lara CLR and Coflux products and our expanding client base reaches across the USA, including major pharma companies such as GSK and Pfizer.
"This new appointment by Radleys ensures that customers in North America will receive the very best sales and technical support".
Mark Radley, managing director of Radleys, commented: "We're confident Lara will offer significant benefits to customers in North America.
"Syrris worked closely with us on the design and development of both Lara and Coflux, and so has great knowledge of these products and is in the ideal position to service the US market".
Syrris will be exhibiting Lara and Coflux at the forthcoming Cambridge Healthcare Institute Process R and D Summit in Philadelphia 24-26 October.
Established in 2001, Syrris is one of the fastest growing science SMEs in the UK employing 20 scientists at its facility in Royston (near Cambridge, UK).
Founders Mark Gilligan and Richard Gray come from a background of developing automation products for chemists at companies such as The Technology Partnership (TTP) and Mettler Toledo Automated Chemistry.
Syrris is creating a family of flow reactor products for discovery and development chemists.
The objective is to reduce the taken time to develop, synthesise, screen and review a chemical entity, from weeks to seconds, thus vastly speeding up the drug discovery process.
Syrris also develops productivity tools in partnership with other companies.
In recognition of its technological achievements, Syrris was awarded a UK DTI Smart Exceptional Grant of £400k in 2003 - one of only 11 to have been awarded since 1998. Request a free brochure from Syrris ...
• Syrris: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
